Published in Respiratory Therapeutics Week, May 9th, 2011
"A total of 1,481 women and 4,631 men with COPD were enrolled in TORCH, a trial comparing salmeterol, 50 mu g, plus fluticasone propionate, 500 pig, twice a day and each component individually: Causes of death were determined by an endpoint committee. Sex differences in survival were explored using a Cox...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Respiratory Therapeutics Week